Patients with preexisting mild-to-moderate aortic stenosis (AS) who exhibit elevated levels of OxPL-apoB, OxPL-apo(a), and lipoprotein(a) experience a significantly accelerated progression of valvular disease and a higher incidence of requiring aortic valve replacement [30]. The gene discussed is AOPEP; the disease is aortic stenosis.